首頁 > 市場調查報告書 > 製藥

生物標記

市場調查報告書

商品編碼

1629616

生物標記研究服務市場按服務類型、適應症、最終用戶和地區分類

Biomarker Research Services Market, By Service Type (Biomarker Research Services and Companion Diagnostics Research Services), By Disease Indication, By End User,By Geography .

出版日期: 2024年12月17日 | 出版商:

Coherent Market Insights | 英文 178 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024 年全球生物標記發現服務市場規模估計為 68.1 億美元，預計 2031 年將達到 1,911 億美元，2024 年至 2031 年的複合年成長率為 61%。

報告範圍		報告詳細資訊
基準年	2023	2024 年的市場規模	68.1億美元
效能資料	2019 年至 2023 年	預測期	2024 年至 2031 年
預測期間 2024 年至 2031 年複合年成長率：	61.00％	2031 年價值預測	1911億美元

圖。

由於精準醫療和個人化醫療的日益普及，全球生物標記發現服務市場在過去幾年中獲得了顯著的發展。生物標記透過識別疾病風險和患者對治療的反應在藥物開發中發揮重要作用。生物標記可以幫助簡化臨床試驗並降低與藥物開發相關的成本。由於生物標記在疾病早期診斷和標靶治療開發中越來越受到關注，對生物標記發現的外包服務的需求巨大。各種生物製藥公司與研究機構合作，以利用他們的專業知識並最大限度地提高臨床研究的效率。這推動了全球生物標記發現服務市場的成長。

市場動態：

全球生物標記發現服務市場受到個人化醫療需求的不斷成長、精準醫療影響力的不斷擴大以及伴同性診斷市場的成長的推動。然而，與生物標記發現和檢驗相關的高成本以及生物標記發現的技術挑戰可能會抑制市場成長。同時，對罕見疾病診斷的日益關注表明該行業參與者俱有巨大的成長潛力。生物標記在罕見疾病藥物開發中發揮重要作用。生物標記的使用可以幫助識別適合臨床試驗的患者並降低成本。基因組學和蛋白質組學等生物標記分析技術的日益普及將在不久的將來帶來豐厚的商機。

本研究的主要特點

本報告對全球生物標記發現服務市場進行了詳細分析，並提供了預測期（2024-2031）的市場規模和年複合成長率（CAGR%），假設 2023 年為基準年。

它還強調了各個領域的潛在商機並說明了該市場的有吸引力的投資提案矩陣。

它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。

全球生物標記發現服務市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數進行的分析。

研究涉及的主要企業包括 F. Hoffmann-La Roche Ltd.、雅培實驗室、賽默飛世爾科技公司、Bio-Rad Laboratories, Inc.、西門子醫療公司、強生服務公司、Qiagen、Epigenetics AG、通用電氣、默克公司、Illumina, Inc.、珀金埃爾默公司、安諾華、通用電氣公司和華倫科技公司。

本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。

全球生物標記發現服務市場報告迎合了該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。

相關人員可以透過用於分析全球生物標記發現服務市場的各種策略矩陣來更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2023	Market Size in 2024:	US$ 6.81 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	61.00%	2031 Value Projection:	US$ 191.10 Bn

The global biomarker research services market has been gaining significant traction over the recent past, owing to rising penetration of precision medicine and personalized healthcare. Biomarkers play a crucial role in drug development by identifying the risk of diseases and patients' response to therapies. They help streamline clinical trials and reduce costs associated with drug development. With increasing focus on biomarkers for early diagnosis of diseases and the development of targeted therapies, there has been huge demand for outsourced biomarker research services. Various biopharmaceutical companies are collaborating with research organizations to tap into their expertise and maximize efficiency of clinical research. This has boosted the growth of the global biomarker research services market.

Market Dynamics:

Global biomarker research services market is driven by rising demand for personalized medicine, increasing influence of precision medicine, and growth of companion diagnostics market. However, high costs associated with biomarker discovery and validation, and technical challenges in biomarker discovery are likely to restrain the market growth. Meanwhile, increasing focus on rare disease diagnosis presents high growth potential for players in this industry. Biomarkers play a critical role in drug development for rare diseases. Their use helps identify patients suitable for clinical trials and reduces costs. Growing adoption of biomarker profiling technologies, such as genomics and proteomics, offer lucrative opportunities in the near future.

Key Features of the Study:

This report provides in-depth analysis of the global biomarker research services market, and provides market size (US$ Billion) and the compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global biomarker research services market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Siemens Healthineers AG, Johnson & Johnson Services, Inc., Qiagen, Epigenetics AG, General Electric, Merck KGaA, Illumina, Inc., PerkinElmer, Inc., Agilent Technologies, Becton, Dickinson and Company, and Novartis AG

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global biomarker research services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biomarker research services market

Market Segmentation

By Service Type Insights (Revenue, USD Bn, 2019 - 2031)
- Biomarker Research Services
- Companion Diagnostics (CDx) Research Services
By Disease Indication Insights (Revenue, USD Bn, 2019 - 2031)
- Cancer
- Cardiovascular Disorders
- Infectious Diseases
- Neurological Disorders
- Immunological Disorders
- Others
By End User Insights (Revenue, USD Bn, 2019 - 2031)
- Hospitals
- Diagnostic Centers
- Specialty Centers
- Research Institutions
Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- F.Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories, Inc.
- Siemens Healthineers AG
- Johnson & Johnson Services, Inc.
- Qiagen
- Epigenetics AG
- General Electric
- Merck KGaA
- Illumina, Inc.
- PerkinElmer, Inc.
- Agilent Technologies
- Becton, Dickinson and Company
- Novartis AG

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Biomarker Research Services Market, By Service Type
- Global Biomarker Research Services Market, By Disease Indication
- Global Biomarker Research Services Market, By End User
- Global Biomarker Research Services Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Biomarker Research Services Market, By Service Type, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Biomarker Research Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Companion Diagnostics (CDx) Research Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Biomarker Research Services Market, By Disease Indication, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cardiovascular Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Immunological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Biomarker Research Services Market, By End User, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Specialty Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Biomarker Research Services Market, By Region, 2019 - 2031, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Service Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Service Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Service Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Service Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Service Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Disease Indication , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Service Type , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Siemens Healthineers AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson & Johnson Services, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Qiagen
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Epigenetics AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
General Electric
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Illumina, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
PerkinElmer, Inc.
Agilent Technologies
Becton, Dickinson and Company
Novartis AG